{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:31:05Z","timestamp":1790760665990,"version":"4.1.0"},"reference-count":323,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Italian Ministry of University and Research","award":["2017AY8BP4"],"award-info":[{"award-number":["2017AY8BP4"]}]},{"name":"PON \u201cRicerca e Innovazione\u201d PerMedNet"},{"name":"Sumitomo Dainippon Pharma"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.pharmthera.2020.107520","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T04:22:43Z","timestamp":1583727763000},"page":"107520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention"],"prefix":"10.1016","volume":"210","author":[{"given":"Andrea Carlo","family":"Rossetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Serena","family":"Paladini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Andrea","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Molteni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1515\/jbcpp-2012-0022","article-title":"Brain and liver oxidative stress after sertraline and haloperidol treatment in mice","volume":"24","author":"Abdel-Salam","year":"2013","journal-title":"Journal of Basic and Clinical Physiology and Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107520_bb0010","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1212\/WNL.57.8.1515","article-title":"Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease","volume":"57","author":"Adair","year":"2001","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107520_bb0015","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00210-018-1552-y","article-title":"Vinpocetine halts ketamine-induced schizophrenia-like deficits in rats: Impact on BDNF and GSK-3\u03b2\/\u03b2-catenin pathway","volume":"391","author":"Ahmed","year":"2018","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pnpbp.2004.10.014","article-title":"Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia","volume":"29","author":"Akyol","year":"2005","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12868-016-0245-z","article-title":"Astaxanthin ameliorates prenatal LPS-exposed behavioral deficits and oxidative stress in adult offspring","volume":"17","author":"Al-Amin","year":"2016","journal-title":"BMC Neuroscience"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/1535370215619707","article-title":"Possible involvement of the JAK\/STAT signaling pathway in N-acetylcysteine-mediated antidepressant-like effects","volume":"241","author":"Al-Samhari","year":"2016","journal-title":"Experimental Biology and Medicine (Maywood, N.J.)"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107520_bb0035","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1515\/CCLM.2000.201","article-title":"Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients","volume":"38","author":"Altuntas","year":"2000","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2015.02.028","article-title":"Effects of haloperidol and clozapine administration on oxidative stress in rat brain, liver and serum","volume":"591","author":"Andreazza","year":"2015","journal-title":"Neuroscience Letters"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107520_bb0045","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1111\/j.1742-4658.2009.06984.x","article-title":"Typical 2-Cys peroxiredoxins--modulation by covalent transformations and noncovalent interactions","volume":"276","author":"Aran","year":"2009","journal-title":"The FEBS Journal"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb0050","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00001756-200403220-00020","article-title":"Expression of nNOS and soluble guanylate cyclase in schizophrenic brain","volume":"15","author":"Baba","year":"2004","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb0055","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s12031-018-1165-4","article-title":"Serum oxidative stress marker levels in unmedicated and medicated patients with schizophrenia","volume":"66","author":"Bai","year":"2018","journal-title":"Journal of Molecular Neuroscience"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb0060","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.pra.0000388627.36781.6a","article-title":"Clozapine treatment causes oxidation of proteins involved in energy metabolism in lymphoblastoid cells: A possible mechanism for antipsychotic-induced metabolic alterations","volume":"16","author":"Baig","year":"2010","journal-title":"Journal of Psychiatric Practice"},{"issue":"20","key":"10.1016\/j.pharmthera.2020.107520_bb0065","doi-asserted-by":"crossref","first-page":"9134","DOI":"10.1523\/JNEUROSCI.22-20-09134.2002","article-title":"The origin and neuronal function of in vivo nonsynaptic glutamate","volume":"22","author":"Baker","year":"2002","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brainres.2019.03.020","article-title":"Sericin alleviates restraint stress induced depressive- and anxiety-like behaviors via modulation of oxidative stress, neuroinflammation and apoptosis in the prefrontal cortex and hippocampus","volume":"1715","author":"Banagozar Mohammadi","year":"2019","journal-title":"Brain Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb0075","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2174\/1570159X14666160229114755","article-title":"Mitochondrial dysfunction in depression","volume":"14","author":"Bansal","year":"2016","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.taap.2018.07.010","article-title":"Naringenin protects against oxido-inflammatory aberrations and altered tryptophan metabolism in olfactory bulbectomized-mice model of depression","volume":"355","author":"Bansal","year":"2018","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/CS20160009","article-title":"Cellular and molecular mechanisms of the brain-derived neurotrophic factor in physiological and pathological conditions","volume":"131","author":"Begni","year":"2017","journal-title":"Clinical Science (London, England)"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107520_bb0090","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1089\/ars.2010.3567","article-title":"CNS peroxiredoxins and their regulation in health and disease","volume":"14","author":"Bell","year":"2011","journal-title":"Antioxidants & Redox Signaling"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb5010","first-page":"355","article-title":"Effect of acetyl-L-carnitine on geriatric patients suffering from dysthymic disorders.","volume":"10","author":"Bella","year":"1990","journal-title":"International Journal of Clinical Pharmacology research"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb0095","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1046\/j.1471-4159.2002.01263.x","article-title":"Mitochondrial dysfunction in schizophrenia: A possible linkage to dopamine","volume":"83","author":"Ben-Shachar","year":"2002","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2018.12.002","article-title":"Brain changes in a maternal immune activation model of neurodevelopmental brain disorders","volume":"175","author":"Bergdolt","year":"2019","journal-title":"Progress in Neurobiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb0105","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","article-title":"N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb0110","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4088\/JCP.13m08454","article-title":"The efficacy of adjunctive N-acetylcysteine in major depressive disorder: A double-blind, randomized, placebo-controlled trial","volume":"75","author":"Berk","year":"2014","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","article-title":"The promise of N-acetylcysteine in neuropsychiatry","volume":"34","author":"Berk","year":"2013","journal-title":"Trends in Pharmacological Sciences"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107520_bb0120","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.euroneuro.2012.11.013","article-title":"L-Acetylcarnitine in dysthymic disorder in elderly patients: A double-blind, multicenter, controlled randomized study vs. fluoxetine","volume":"23","author":"Bersani","year":"2013","journal-title":"European Neuropsychopharmacology"},{"issue":"28","key":"10.1016\/j.pharmthera.2020.107520_bb0130","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.1073\/pnas.1603111113","article-title":"Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: Implications for treatment resistance","volume":"113","author":"Bigio","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-0327(00)00199-3","article-title":"Antioxidative enzyme activities and lipid peroxidation in major depression: Alterations by antidepressant treatments","volume":"64","author":"Bilici","year":"2001","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb0140","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","article-title":"Oxidative stress in schizophrenia: An integrated approach","volume":"35","author":"Bitanihirwe","year":"2011","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.psyneuen.2014.09.025","article-title":"Is depression associated with increased oxidative stress? A systematic review and meta-analysis","volume":"51","author":"Black","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107520_bb0150","first-page":"511","article-title":"Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain","volume":"24","author":"Bonavita","year":"1986","journal-title":"International Journal of Clinical Pharmacology, Therapy, and Toxicology"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb0155","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/157015911795596595","article-title":"Oxidative stress in schizophrenia","volume":"9","author":"Bo\u0161kovi\u0107","year":"2011","journal-title":"Current Neuropharmacology"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107520_bb0160","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/mp.2016.211","article-title":"Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression","volume":"22","author":"Bouvier","year":"2017","journal-title":"Molecular Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb0165","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nature Reviews. Neuroscience"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb0170","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.neuron.2014.07.028","article-title":"Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia","volume":"83","author":"Cabungcal","year":"2014","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb7000","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.biopsych.2012.09.020","article-title":"Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine.","volume":"73","author":"Cabungcal","year":"2013","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0175","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.schres.2019.02.017","article-title":"A developmental redox dysregulation leads to spatio-temporal deficit of parvalbumin neuron circuitry in a schizophrenia mouse model","volume":"213","author":"Cabungcal","year":"2019","journal-title":"Schizophrenia Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.94","article-title":"Therapeutic efficacy of atypical antipsychotic drugs by targeting multiple stress-related metabolic pathways","volume":"7","author":"Cai","year":"2017","journal-title":"Translational Psychiatry"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107520_bb0185","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1080\/14728222.2016.1188080","article-title":"Synaptic alterations associated with depression and schizophrenia: Potential as a therapeutic target","volume":"20","author":"Calabrese","year":"2016","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0190","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejphar.2018.07.002","article-title":"Cholecalciferol counteracts depressive-like behavior and oxidative stress induced by repeated corticosterone treatment in mice","volume":"833","author":"Camargo","year":"2018","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.psychres.2016.01.075","article-title":"Evaluation of malondialdehyde, superoxide dismutase and catalase activity and their diagnostic value in drug na\u00efve, first episode, non-smoker major depression patients and healthy controls","volume":"238","author":"Camkurt","year":"2016","journal-title":"Psychiatry Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029341","article-title":"Glutathione precursor N-acetyl-cysteine modulates EEG synchronization in schizophrenia patients: A double-blind, randomized, placebo-controlled trial","volume":"7","author":"Carmeli","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107520_bb0205","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1007\/s00213-018-5151-x","article-title":"The selenium-containing compound 3-((4-chlorophenyl)selanyl)-1-methyl-1H-indole reverses depressive-like behavior induced by acute restraint stress in mice: Modulation of oxido-nitrosative stress and inflammatory pathway","volume":"236","author":"Casaril","year":"2019","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107520_bb0210","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1177\/0269881117711713","article-title":"Antidepressant-like effect of a new selenium-containing compound is accompanied by a reduction of neuroinflammation and oxidative stress in lipopolysaccharide-challenged mice","volume":"31","author":"Casaril","year":"2017","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0215","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2147\/NDT.S157475","article-title":"Novel treatment options in depression and psychosis","volume":"14","author":"Ceskova","year":"2018","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107520_bb0220","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrendo.2017.69","article-title":"The gentle art of saying NO: How nitric oxide gets things done in the hypothalamus","volume":"13","author":"Chachlaki","year":"2017","journal-title":"Nature Reviews. Endocrinology"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060654","article-title":"Resveratrol confers protection against rotenone-induced neurotoxicity by modulating myeloperoxidase levels in glial cells","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/nu11040859","article-title":"The Chinese herbal formula PAPZ ameliorates behavioral abnormalities in depressive mice","volume":"11","author":"Chen","year":"2019","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb0235","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00213-010-1802-2","article-title":"The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice","volume":"209","author":"Chen","year":"2010","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0240","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pnpbp.2012.05.018","article-title":"Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex","volume":"39","author":"Chiba","year":"2012","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010011","article-title":"l-Acetylcarnitine: A mechanistically distinctive and potentially rapid-acting antidepressant drug","volume":"19","author":"Chiechio","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"issue":"28","key":"10.1016\/j.pharmthera.2020.107520_bb0250","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1523\/JNEUROSCI.0970-05.2005","article-title":"Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson\u2019s disease in mice","volume":"25","author":"Choi","year":"2005","journal-title":"The Journal of Neuroscience"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107520_bb0255","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1089\/ars.2010.3508","article-title":"Genetic association studies of antioxidant pathway genes and schizophrenia","volume":"15","author":"Chowdari","year":"2011","journal-title":"Antioxidants & Redox Signaling"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2020.107520_bb0260","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.psychres.2012.10.018","article-title":"Increased oxidative stress in patients with depression and its relationship to treatment","volume":"206","author":"Chung","year":"2013","journal-title":"Psychiatry Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107520_bb0265","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/S0021-9258(19)42751-8","article-title":"The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents","volume":"249","author":"Cohen","year":"1974","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb0270","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/schbul\/sbx093","article-title":"N-acetylcysteine in a double-blind randomized placebo-controlled trial: Toward biomarker-guided treatment in early psychosis","volume":"44","author":"Conus","year":"2018","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0275","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1742-2094-10-155","article-title":"Cellular and temporal expression of NADPH oxidase (NOX) isotypes after brain injury","volume":"10","author":"Cooney","year":"2013","journal-title":"Journal of Neuroinflammation"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb0280","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1074\/jbc.M608083200","article-title":"ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages","volume":"282","author":"Cruz","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107520_bb0285","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/npp.2013.121","article-title":"Upregulation of mGlu2 receptors via NF-\u03baB p65 acetylation is involved in the proneurogenic and antidepressant effects of acetyl-L-carnitine","volume":"38","author":"Cuccurazzu","year":"2013","journal-title":"Neuropsycho-pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb0290","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1440-1819.2009.02004.x","article-title":"Total antioxidant capacity and total oxidant status in patients with major depression: Impact of antidepressant treatment","volume":"63","author":"Cumurcu","year":"2009","journal-title":"Psychiatry and Clinical Neurosciences"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2020.107520_bb0295","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1006912010550","article-title":"Fluoxetine interacts with the lipid bilayer of the inner membrane in isolated rat brain mitochondria, inhibiting electron transport and F1F0-ATPase activity","volume":"199","author":"Curti","year":"1999","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0300","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13041-019-0463-2","article-title":"Predictable chronic mild stress promotes recovery from LPS-induced depression","volume":"12","author":"Dang","year":"2019","journal-title":"Molecular Brain"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0305","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: When the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nature Reviews. Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb0310","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1503\/jpn.100057","article-title":"N-acetylcysteine in psychiatry: Current therapeutic evidence and potential mechanisms of action","volume":"36","author":"Dean","year":"2011","journal-title":"Journal of Psychiatry & Neuroscience"},{"issue":"16","key":"10.1016\/j.pharmthera.2020.107520_bb0320","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1021\/bi973035t","article-title":"Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: Evidence for a sulfenic acid intermediate and implications for redox regulation","volume":"37","author":"Denu","year":"1998","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb0325","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/cclm-2015-0212","article-title":"Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: A case control study","volume":"54","author":"Devanarayanan","year":"2016","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb0330","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00213-011-2326-0","article-title":"Antidepressant-like effect of artemin in mice: A mechanism for acetyl-L-carnitine activity on depression","volume":"218","author":"Di Cesare Mannelli","year":"2011","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb0335","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/jphp.13039","article-title":"Standardized extract of Erythrina velutina Willd. attenuates schizophrenia-Like behaviours and oxidative parameters in experimental animal models","volume":"71","author":"Dias","year":"2019","journal-title":"The Journal of Pharmacy and Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb0340","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/pcn.12631","article-title":"Comparative effects of aripiprazole and selected antipsychotic drugs on lipid peroxidation in plasma","volume":"72","author":"Dietrich-Muszalska","year":"2018","journal-title":"Psychiatry and Clinical Neurosciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000202822","article-title":"Oxidative\/nitrative modifications of plasma proteins and thiols from patients with schizophrenia","volume":"59","author":"Dietrich-Muszalska","year":"2009","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0350","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.psychres.2007.07.019","article-title":"Increased plasma levels of 8-iso-PGF2alpha and IL-6 in an elderly population with depression","volume":"161","author":"Dimopoulos","year":"2008","journal-title":"Psychiatry Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107520_bb0355","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","article-title":"Schizophrenia: Glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo","volume":"12","author":"Do","year":"2000","journal-title":"The European Journal of Neuroscience"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107520_bb0360","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/14728220802517901","article-title":"N-acetylcysteine for antioxidant therapy: Pharmacology and clinical utility","volume":"8","author":"Dodd","year":"2008","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107520_bb0365","first-page":"3354","article-title":"Antipsychotic-like effect of minocycline in a rat model","volume":"7","author":"Dokuyucu","year":"2014","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"36","key":"10.1016\/j.pharmthera.2020.107520_bb0370","doi-asserted-by":"crossref","first-page":"27850","DOI":"10.1074\/jbc.M110.101196","article-title":"Respiration-dependent H2O2 removal in brain mitochondria via the thioredoxin\/peroxiredoxin system","volume":"285","author":"Drechsel","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb0375","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/BC.2003.059","article-title":"Glutathione pathways in the brain","volume":"384","author":"Dringen","year":"2003","journal-title":"Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0380","article-title":"MMP9\/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory\/excitatory imbalance: A reverse translation study in schizophrenia patients","author":"Dwir","year":"2019","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0385","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.freeradbiomed.2017.02.002","article-title":"Genotoxicity of lipid oxidation compounds","volume":"111","author":"Eckl","year":"2017","journal-title":"Free Radical Biology & Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0390","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/BJ20090471","article-title":"Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1","volume":"422","author":"Eggler","year":"2009","journal-title":"The Biochemical Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb0395","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/A:1020214322065","article-title":"Apomorphine susceptibility and animal models for psychopathology: Genes and environment","volume":"32","author":"Ellenbroek","year":"2002","journal-title":"Behavior Genetics"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb0405","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/WNF.0000000000000001","article-title":"N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: A randomized, double-blind, placebo-controlled study","volume":"36","author":"Farokhnia","year":"2013","journal-title":"Clinical Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0410","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41598-018-38085-2","article-title":"Effects of chronic unpredictable mild stress induced prenatal stress on neurodevelopment of neonates: Role of GSK-3\u03b2","volume":"9","author":"Fatima","year":"2019","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb0415","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.4088\/JCP.15r09984","article-title":"N-Acetylcysteine in depressive symptoms and functionality: A systematic review and meta-analysis","volume":"77","author":"Fernandes","year":"2016","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0420","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.bbr.2019.02.025","article-title":"N-acetylcysteine attenuates neuroinflammation associated depressive behavior induced by chronic unpredictable mild stress in rat","volume":"364","author":"Fernandes","year":"2019","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0425","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2015.03.011","article-title":"Functional proteomics of synaptic plasma membrane ATP-ases of rat hippocampus: Effect of l-acetylcarnitine and relationships with dementia and depression pathophysiology","volume":"756","author":"Ferrari","year":"2015","journal-title":"European Journal of Pharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107520_bb0430","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/FBP.0b013e3283123c98","article-title":"Antidepressant-like effects of N-acetyl-L-cysteine in rats","volume":"19","author":"Ferreira","year":"2008","journal-title":"Behavioural Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb0435","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1021\/acs.chemrev.7b00568","article-title":"Biochemistry of peroxynitrite and protein tyrosine nitration","volume":"118","author":"Ferrer-Sueta","year":"2018","journal-title":"Chemical Reviews"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb0440","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.biopsych.2013.03.018","article-title":"Meta-analysis of oxidative stress in schizophrenia","volume":"74","author":"Flatow","year":"2013","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb0445","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.neubiorev.2008.03.003","article-title":"Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders","volume":"32","author":"Fone","year":"2008","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb0450","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ijnp\/pyx015","article-title":"Oxidative stress and inflammation in early onset first episode psychosis: A systematic review and meta-analysis","volume":"20","author":"Fraguas","year":"2017","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0455","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pnpbp.2013.12.012","article-title":"Agmatine abolishes restraint stress-induced depressive-like behavior and hippocampal antioxidant imbalance in mice","volume":"50","author":"Freitas","year":"2014","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0460","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.brainres.2006.04.076","article-title":"Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure","volume":"1097","author":"Frey","year":"2006","journal-title":"Brain Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb0465","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s11064-006-9070-6","article-title":"Changes in antioxidant defense enzymes after d-amphetamine exposure: Implications as an animal model of mania","volume":"31","author":"Frey","year":"2006","journal-title":"Neurochemical Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb0470","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0269881113512909","article-title":"Reviewing the ketamine model for schizophrenia","volume":"28","author":"Frohlich","year":"2014","journal-title":"Journal of Psychopharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb0475","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pneurobio.2007.01.002","article-title":"Stress during development: Impact on neuroplasticity and relevance to psychopathology","volume":"81","author":"Fumagalli","year":"2007","journal-title":"Progress in Neurobiology"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2020.107520_bb0480","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jad.2010.09.005","article-title":"Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder","volume":"129","author":"Ga\u0142ecki","year":"2011","journal-title":"Journal of Affective Disorders"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb0485","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11011-019-0389-5","article-title":"Antidepressive effects of kaempferol mediated by reduction of oxidative stress, proinflammatory cytokines and up-regulation of AKT\/\u03b2-catenin cascade","volume":"34","author":"Gao","year":"2019","journal-title":"Metabolic Brain Disease"},{"issue":"22","key":"10.1016\/j.pharmthera.2020.107520_bb0490","doi-asserted-by":"crossref","first-page":"13399","DOI":"10.1074\/jbc.270.22.13399","article-title":"Superoxide radical and iron modulate aconitase activity in mammalian cells","volume":"270","author":"Gardner","year":"1995","journal-title":"The Journal of Biological Chemistry"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107520_bb0495","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1111\/j.1460-9568.2008.06285.x","article-title":"Concepts of neural nitric oxide-mediated transmission","volume":"27","author":"Garthwaite","year":"2008","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2016.07.004","article-title":"Agmatine ameliorates lipopolysaccharide induced depressive-like behaviour in mice by targeting the underlying inflammatory and oxido-nitrosative mediators","volume":"149","author":"Gawali","year":"2016","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0505","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S1461145710000805","article-title":"Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders","volume":"14","author":"Gawryluk","year":"2011","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"6123","key":"10.1016\/j.pharmthera.2020.107520_bb0510","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1126\/science.1228261","article-title":"Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice","volume":"339","author":"Giovanoli","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0515","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pnpbp.2017.05.014","article-title":"Evaluation of the effectiveness of chronic antidepressant drug treatments in the hippocampal mitochondria - A proteomic study in an animal model of depression","volume":"78","author":"G\u0142ombik","year":"2017","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0520","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neulet.2010.11.006","article-title":"Chronic mild stress damages mitochondrial ultrastructure and function in mouse brain","volume":"488","author":"Gong","year":"2011","journal-title":"Neuroscience Letters"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb0525","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.psychres.2010.10.008","article-title":"Genetic polymorphisms of glutathione S-transferases GSTM1, GSTT1, GSTP1 and GSTA1 as risk factors for schizophrenia","volume":"187","author":"Gravina","year":"2011","journal-title":"Psychiatry Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0530","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1750-3639.2007.00110.x","article-title":"Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis","volume":"18","author":"Gray","year":"2008","journal-title":"Brain Pathology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb0535","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1471-4159.2004.02527.x","article-title":"Neuronal expression of myeloperoxidase is increased in Alzheimer\u2019s disease","volume":"90","author":"Green","year":"2004","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0540","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fncel.2013.00190","article-title":"The role of nitric oxide in pre-synaptic plasticity and homeostasis","volume":"7","author":"Hardingham","year":"2013","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb0545","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neuron.2012.08.019","article-title":"Synaptic energy use and supply","volume":"75","author":"Harris","year":"2012","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb0550","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/abbi.1996.0510","article-title":"The metabolism of tyramine by monoamine oxidase A\/B causes oxidative damage to mitochondrial DNA","volume":"335","author":"Hauptmann","year":"1996","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"13","key":"10.1016\/j.pharmthera.2020.107520_bb0555","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/WNR.0000000000001078","article-title":"Chronic administration of quetiapine attenuates the phencyclidine-induced recognition memory impairment and hippocampal oxidative stress in rats","volume":"29","author":"He","year":"2018","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb0560","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.arcmed.2006.10.005","article-title":"Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: Impact of antidepressant treatment","volume":"38","author":"Herken","year":"2007","journal-title":"Archives of Medical Research"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2020.107520_bb0565","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.schres.2014.03.012","article-title":"N-acetylcysteine prevents increased amphetamine sensitivity in social isolation-reared mice","volume":"155","author":"Herrmann","year":"2014","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0570","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pbb.2015.07.003","article-title":"Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways","volume":"136","author":"Holzmann","year":"2015","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb0575","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881114563634","article-title":"Glutamate and dopamine in schizophrenia: An update for the 21st century","volume":"29","author":"Howes","year":"2015","journal-title":"Journal of Psychopharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb0580","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.mito.2013.05.005","article-title":"Mitochondrial respiration in blood platelets of depressive patients","volume":"13","author":"Hroudov\u00e1","year":"2013","journal-title":"Mitochondrion"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0585","doi-asserted-by":"crossref","first-page":"2153745","DOI":"10.1155\/2016\/2153745","article-title":"Hydrogen sulfide protects against chronic unpredictable mild stress-induced oxidative stress in hippocampus by upregulation of BDNF-TrkB pathway","volume":"2016","author":"Hu","year":"2016","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107520_bb0590","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1073\/pnas.1214912110","article-title":"Cortical energy demands of signaling and nonsignaling components in brain are conserved across mammalian species and activity levels","volume":"110","author":"Hyder","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb0595","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s11011-017-0028-y","article-title":"Acute and chronic treatment with quetiapine induces antidepressant-like behavior and exerts antioxidant effects in the rat brain","volume":"32","author":"Ign\u00e1cio","year":"2017","journal-title":"Metabolic Brain Disease"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0600","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pbb.2015.02.017","article-title":"Type 4 phosphodiesterase enzyme inhibitor, rolipram rescues behavioral deficits in olfactory bulbectomy models of depression: Involvement of hypothalamic-pituitary-adrenal axis, cAMP signaling aspects and antioxidant defense system","volume":"132","author":"Jindal","year":"2015","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"9\u201310","key":"10.1016\/j.pharmthera.2020.107520_bb0605","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1089\/ars.2006.8.1865","article-title":"Redefining oxidative stress","volume":"8","author":"Jones","year":"2006","journal-title":"Antioxidants & Redox Signaling"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0610","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.plipres.2009.08.004","article-title":"Acylcarnitines: Role in brain","volume":"49","author":"Jones","year":"2010","journal-title":"Progress in Lipid Research"},{"issue":"3\u20134","key":"10.1016\/j.pharmthera.2020.107520_bb0615","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/ars.2005.7.395","article-title":"Redox regulation of NF-kappaB activation: Distinct redox regulation between the cytoplasm and the nucleus","volume":"7","author":"Kabe","year":"2005","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0620","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neulet.2015.01.006","article-title":"Potential involvement of the mitochondrial unfolded protein response in depressive-like symptoms in mice","volume":"588","author":"Kambe","year":"2015","journal-title":"Neuroscience Letters"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107520_bb0625","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/jcbfm.2014.104","article-title":"Highly energized inhibitory interneurons are a central element for information processing in cortical networks","volume":"34","author":"Kann","year":"2014","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0630","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.44","article-title":"Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression","volume":"4","author":"Karabatsiakis","year":"2014","journal-title":"Translational Psychiatry"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107520_bb0635","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.biopsych.2003.12.012","article-title":"Mitochondrial complex I subunits expression is altered in schizophrenia: A postmortem study","volume":"55","author":"Karry","year":"2004","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb0640","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/JCP.0b013e3181c163ef","article-title":"Management of clozapine-related hepatotoxicity","volume":"29","author":"Keane","year":"2009","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb0645","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1179\/135100003225003393","article-title":"Oxidative damage and major depression: The potential antioxidant action of selective serotonin re-uptake inhibitors","volume":"8","author":"Khanzode","year":"2003","journal-title":"Redox Report"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb0650","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/jpet.116.235127","article-title":"Myeloperoxidase inhibition increases neurogenesis after ischemic stroke","volume":"359","author":"Kim","year":"2016","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb0655","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.pnpbp.2006.04.008","article-title":"Increased plasma nitric oxide level associated with suicide attempt in depressive patients","volume":"30","author":"Kim","year":"2006","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0660","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41398-018-0266-8","article-title":"N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: A double-blind randomized placebo-controlled trial","volume":"8","author":"Klauser","year":"2018","journal-title":"Translational Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2020.107520_bb0665","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10863-014-9584-6","article-title":"A mitochondrial bioenergetic basis of depression","volume":"47","author":"Klinedinst","year":"2015","journal-title":"Journal of Bioenergetics and Biomembranes"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107520_bb0670","doi-asserted-by":"crossref","DOI":"10.3390\/nu9070659","article-title":"Does Vitamin C influence neurodegenerative diseases and psychiatric disorders?","volume":"9","author":"Kocot","year":"2017","journal-title":"Nutrients"},{"issue":"13\u201314","key":"10.1016\/j.pharmthera.2020.107520_bb0675","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.clinbiochem.2009.06.006","article-title":"Antioxidative enzymes and increased oxidative stress in depressive women","volume":"42","author":"Kodydkov\u00e1","year":"2009","journal-title":"Clinical Biochemistry"},{"issue":"5\u20136","key":"10.1016\/j.pharmthera.2020.107520_bb0680","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/ars.2006.8.813","article-title":"Redox pathways of the mitochondrion","volume":"8","author":"Koehler","year":"2006","journal-title":"Antioxidants & Redox Signaling"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb0685","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1139\/jpn.0528","article-title":"Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide","volume":"30","author":"Kolla","year":"2005","journal-title":"Journal of Psychiatry & Neuroscience"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb0690","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.pnpbp.2011.03.021","article-title":"Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: A 24-week follow-up study","volume":"35","author":"Kotan","year":"2011","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0695","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbr.2010.11.027","article-title":"The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis","volume":"218","author":"Krass","year":"2011","journal-title":"Behavioural Brain Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb0700","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1176\/jnp.17.2.227","article-title":"Oxidative stress during treatment with first- and second-generation antipsychotics","volume":"17","author":"Kropp","year":"2005","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107520_bb0705","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1089\/ars.2012.4858","article-title":"Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: Insights from animal models","volume":"18","author":"Kulak","year":"2013","journal-title":"Antioxidants & Redox Signaling"},{"issue":"9820","key":"10.1016\/j.pharmthera.2020.107520_bb0710","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0140-6736(11)60602-8","article-title":"Major depressive disorder: New clinical, neurobiological, and treatment perspectives","volume":"379","author":"Kupfer","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0715","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbr.2018.02.009","article-title":"Antidepressant activity of vorinostat is associated with amelioration of oxidative stress and inflammation in a corticosterone-induced chronic stress model in mice","volume":"344","author":"Kv","year":"2018","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0720","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-pathol-012513-104651","article-title":"Nox enzymes and new thinking on reactive oxygen: A double-edged sword revisited","volume":"9","author":"Lambeth","year":"2014","journal-title":"Annual Review of Pathology"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb0725","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/hipo.20421","article-title":"Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation","volume":"18","author":"Lant\u00e9","year":"2008","journal-title":"Hippocampus"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107520_bb0730","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/sj.npp.1301624","article-title":"Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients","volume":"33","author":"Lavoie","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2020.107520_bb0735","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.schres.2016.06.011","article-title":"Elevated plasma F2-isoprostane levels in schizophrenia","volume":"176","author":"Lee","year":"2016","journal-title":"Schizophrenia Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb0740","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4088\/JCP.09r05268yel","article-title":"Antipsychotic medication and oxidative cell stress: A systematic review","volume":"72","author":"Lepping","year":"2011","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0745","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tins.2011.10.004","article-title":"Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia","volume":"35","author":"Lewis","year":"2012","journal-title":"Trends in Neurosciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb0750","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0755","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.neubiorev.2015.05.014","article-title":"Inflammation in schizophrenia: A question of balance","volume":"55","author":"Leza","year":"2015","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0760","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.biopha.2018.01.137","article-title":"Apocynum venetum leaf extract reverses depressive-like behaviors in chronically stressed rats by inhibiting oxidative stress and apoptosis","volume":"100","author":"Li","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0765","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuint.2018.07.007","article-title":"Riparin II ameliorates corticosterone-induced depressive-like behavior in mice: Role of antioxidant and neurotrophic mechanisms","volume":"120","author":"Lopes","year":"2018","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0770","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pnpbp.2013.09.017","article-title":"A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers","volume":"48","author":"Lopresti","year":"2014","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0775","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-244X-14-123","article-title":"Decreased plasma neuroactive amino acids and increased nitric oxide levels in melancholic major depressive disorder","volume":"14","author":"Lu","year":"2014","journal-title":"BMC Psychiatry"},{"issue":"5\u20136","key":"10.1016\/j.pharmthera.2020.107520_bb0780","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neuint.2009.01.001","article-title":"Effects of chronic mild stress on the oxidative parameters in the rat brain","volume":"54","author":"Lucca","year":"2009","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0785","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.yfrne.2018.02.001","article-title":"The effects of chronic stress on the human brain: From neurotoxicity, to vulnerability, to opportunity","volume":"49","author":"Lupien","year":"2018","journal-title":"Frontiers in Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0790","doi-asserted-by":"crossref","first-page":"736837","DOI":"10.1155\/2012\/736837","article-title":"Glutathione homeostasis and functions: Potential targets for medical interventions","volume":"2012","author":"Lushchak","year":"2012","journal-title":"Journal of Amino Acids"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0795","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jpsychires.2019.04.008","article-title":"Chronic mild stress induced anxiety-like behaviors can be attenuated by inhibition of NOX2-derived oxidative stress","volume":"114","author":"Lv","year":"2019","journal-title":"Journal of Psychiatric Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107520_bb0800","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.138","article-title":"Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia","volume":"7","author":"Maas","year":"2017","journal-title":"Translational Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb0805","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s13311-016-0438-2","article-title":"The atypical antipsychotic paliperidone regulates endogenous antioxidant\/anti-Inflammatory pathways in rat models of acute and chronic restraint stress","volume":"13","author":"MacDowell","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0810","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2016.12.025","article-title":"Paliperidone reverts Toll-like receptor 3 signaling pathway activation and cognitive deficits in a maternal immune activation mouse model of schizophrenia","volume":"116","author":"MacDowell","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0815","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1515\/jbcpp-2013-0011","article-title":"Resveratrol for prenatal-stress-induced oxidative damage in growing brain and its consequences on survival of neurons","volume":"25","author":"Madhyastha","year":"2014","journal-title":"Journal of Basic and Clinical Physiology and Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb0820","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","article-title":"A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness","volume":"35","author":"Maes","year":"2011","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0825","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12035-018-1051-7","article-title":"Major differences in neurooxidative and neuronitrosative stress pathways between major depressive disorder and types I and II bipolar disorder","volume":"56","author":"Maes","year":"2019","journal-title":"Molecular Neurobiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb0830","first-page":"462","article-title":"Lower plasma Coenzyme Q10 in depression: A marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness","volume":"30","author":"Maes","year":"2009","journal-title":"Neuro Endocrinology Letters"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2020.107520_bb0835","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jad.2009.12.014","article-title":"Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: Markers that further explain the higher incidence of neurodegeneration and coronary artery disease","volume":"125","author":"Maes","year":"2010","journal-title":"Journal of Affective Disorders"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb0840","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuron.2015.03.035","article-title":"A cellular perspective on brain energy metabolism and functional imaging","volume":"86","author":"Magistretti","year":"2015","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb0845","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-0031-1301326","article-title":"Reversal of oxidative stress by histamine H3 receptor-ligands in experimental models of schizophrenia","volume":"62","author":"Mahmood","year":"2012","journal-title":"Arzneimittelforschung"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb0850","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1037\/rev0000033","article-title":"Learned helplessness at fifty: Insights from neuroscience","volume":"123","author":"Maier","year":"2016","journal-title":"Psychological Review"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb0855","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.M807731200","article-title":"Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease","volume":"284","author":"Maki","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0860","doi-asserted-by":"crossref","first-page":"7390516","DOI":"10.1155\/2017\/7390516","article-title":"Long-term effects of maternal deprivation on redox regulation in rat brain: Involvement of NADPH oxidase","volume":"2017","author":"Markovi\u0107","year":"2017","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107520_bb0865","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.psyneuen.2013.03.020","article-title":"Nrf2 participates in depressive disorders through an anti-inflammatory mechanism","volume":"38","author":"Mart\u00edn-de-Saavedra","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0870","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuropharm.2015.11.029","article-title":"Modulation of the antioxidant nuclear factor (erythroid 2-derived)-like 2 pathway by antidepressants in rats","volume":"103","author":"Mart\u00edn-Hern\u00e1ndez","year":"2016","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0875","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03033368","article-title":"Antipsychotic-induced oxidative stress in rat brain","volume":"13","author":"Martins","year":"2008","journal-title":"Neurotoxicity Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107520_bb0880","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jpsychires.2008.11.006","article-title":"Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia","volume":"43","author":"Martins-de-Souza","year":"2009","journal-title":"Journal of Psychiatric Research"},{"issue":"15","key":"10.1016\/j.pharmthera.2020.107520_bb0885","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1093\/nar\/20.15.3821","article-title":"Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62","volume":"20","author":"Matthews","year":"1992","journal-title":"Nucleic Acids Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107520_bb0890","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jpsychires.2006.02.010","article-title":"Increased lipid peroxidation and neuron specific enolase in treatment refractory schizophrenics","volume":"41","author":"Medina-Hern\u00e1ndez","year":"2007","journal-title":"Journal of Psychiatric Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb0895","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153380","article-title":"Comparative safety of pharmacologic treatments for persistent depressive disorder: A systematic review and network meta-analysis","volume":"11","author":"Meister","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0900","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2015.04.036","article-title":"Nrf2-signaling and BDNF: A new target for the antidepressant-like activity of chronic fluoxetine treatment in a mouse model of anxiety\/depression","volume":"597","author":"Mendez-David","year":"2015","journal-title":"Neuroscience Letters"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107520_bb0905","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.tins.2019.08.001","article-title":"Neurodevelopmental resilience and susceptibility to maternal immune activation","volume":"42","author":"Meyer","year":"2019","journal-title":"Trends in Neurosciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hup.2272","article-title":"Effect of atypical antipsychotics on antioxidant enzyme activities in human erythrocytes (in vitro study)","volume":"28","author":"Miljevi\u0107","year":"2013","journal-title":"Human Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb0915","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/17425255.2017.1251580","article-title":"N-acetylcysteine in the treatment of psychiatric disorders: Current status and future prospects","volume":"13","author":"Minarini","year":"2017","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb0920","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.euroneuro.2010.09.006","article-title":"Isolation rearing-induced deficits in sensorimotor gating and social interaction in rats are related to cortico-striatal oxidative stress, and reversed by sub-chronic clozapine administration","volume":"21","author":"M\u00f6ller","year":"2011","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0925","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bbi.2012.12.011","article-title":"Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine","volume":"30","author":"M\u00f6ller","year":"2013","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0935","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbr.2017.04.057","article-title":"Two-hit model of schizophrenia induced by neonatal immune activation and peripubertal stress in rats: Study of sex differences and brain oxidative alterations","volume":"331","author":"Monte","year":"2017","journal-title":"Behavioural Brain Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb0940","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s11011-018-0209-3","article-title":"In major affective disorders, early life trauma predict increased nitro-oxidative stress, lipid peroxidation and protein oxidation and recurrence of major affective disorders, suicidal behaviors and a lowered quality of life","volume":"33","author":"Moraes","year":"2018","journal-title":"Metabolic Brain Disease"},{"key":"10.1016\/j.pharmthera.2020.107520_bb0945","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbr.2016.09.029","article-title":"The olfactory bulbectomized rat as a model of depression: The hippocampal pathway","volume":"317","author":"Morales-Medina","year":"2017","journal-title":"Behavioural Brain Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb0950","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.psychres.2012.12.024","article-title":"Increase in nitric oxide levels and mitochondrial membrane potential in platelets of untreated patients with major depression","volume":"209","author":"Moreno","year":"2013","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb0955","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jpsychires.2011.11.002","article-title":"Oral treatment with amitriptyline induces coenzyme Q deficiency and oxidative stress in psychiatric patients","volume":"46","author":"Moreno-Fern\u00e1ndez","year":"2012","journal-title":"Journal of Psychiatric Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb0960","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s12035-014-8705-x","article-title":"The glutathione system: A new drug target in neuroimmune disorders","volume":"50","author":"Morris","year":"2014","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0965","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"The Biochemical Journal"},{"issue":"22","key":"10.1016\/j.pharmthera.2020.107520_bb0970","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1016\/j.febslet.2005.08.020","article-title":"Fluoxetine (Prozac) interaction with the mitochondrial voltage-dependent anion channel and protection against apoptotic cell death","volume":"579","author":"Nahon","year":"2005","journal-title":"FEBS Letters"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb0975","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hup.1102","article-title":"Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: A pilot study","volume":"25","author":"Nakano","year":"2010","journal-title":"Human Psychopharmacology"},{"issue":"34","key":"10.1016\/j.pharmthera.2020.107520_bb0980","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1073\/pnas.1801609115","article-title":"Acetyl-l-carnitine deficiency in patients with major depressive disorder","volume":"115","author":"Nasca","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107520_bb0985","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1073\/pnas.1216100110","article-title":"L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors","volume":"110","author":"Nasca","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb0990","doi-asserted-by":"crossref","first-page":"65","DOI":"10.14348\/molcells.2016.2349","article-title":"The roles of peroxiredoxin and thioredoxin in hydrogen peroxide sensing and in signal transduction","volume":"39","author":"Netto","year":"2016","journal-title":"Molecules and Cells"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2020.107520_bb0995","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1388-1981(00)00119-0","article-title":"Phospholipase A(2)s and lipid peroxidation","volume":"1488","author":"Nigam","year":"2000","journal-title":"Biochimica et Biophysica Acta"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb1000","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00019442-200403000-00008","article-title":"Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia","volume":"12","author":"Nishioka","year":"2004","journal-title":"The American Journal of Geriatric Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb1005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12640-012-9331-x","article-title":"Oxidative damage to RNA in aging and neurodegenerative disorders","volume":"22","author":"Nunomura","year":"2012","journal-title":"Neurotoxicity Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb1010","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/schbul\/sbu048","article-title":"Oxidative\/nitrosative stress in psychiatric disorders: Are we there yet?","volume":"40","author":"O\u2019Donnell","year":"2014","journal-title":"Schizophrenia Bulletin"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb1015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pharep.2017.08.008","article-title":"Changes in the concentrations of inflammatory and oxidative status biomediators (MIP-1 \u03b1, PMN elastase, MDA, and IL-12) in depressed patients with and without posttraumatic stress disorder","volume":"70","author":"Og\u0142odek","year":"2018","journal-title":"Pharmacological Reports"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb1020","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.pnpbp.2009.05.010","article-title":"Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats","volume":"33","author":"de Oliveira","year":"2009","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb1025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1590\/S0100-879X2008000400012","article-title":"Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders","volume":"41","author":"Oliveira","year":"2008","journal-title":"Brazilian Journal of Medical and Biological Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb1030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.29252\/nirp.bcn.9.3.195","article-title":"Protective effects of morin hydrate on acute stress-induced behavioral and biochemical alterations in mice","volume":"9","author":"Olonode","year":"2018","journal-title":"Basic and Clinical Neuroscience"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107520_bb1035","first-page":"994","article-title":"Antidepressant-like actions of inhibitors of poly(ADP-Ribose) polymerase in rodent models","volume":"20","author":"Ordway","year":"2017","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"10039","key":"10.1016\/j.pharmthera.2020.107520_bb1045","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb1050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neulet.2010.05.088","article-title":"Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics","volume":"479","author":"Padurariu","year":"2010","journal-title":"Neuroscience Letters"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107520_bb1055","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.tips.2016.06.007","article-title":"Targeting oxidative stress in central nervous system disorders","volume":"37","author":"Patel","year":"2016","journal-title":"Trends in Pharmacological Sciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb1065","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1440-1819.2009.02015.x","article-title":"Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile","volume":"63","author":"Pazvantoglu","year":"2009","journal-title":"Psychiatry and Clinical Neurosciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb1070","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0081-17.2017","article-title":"Antioxidant treatment in male mice prevents mitochondrial and synaptic changes in an NMDA receptor dysfunction model of Schizophrenia","volume":"4","author":"Phensy","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1075","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fphys.2013.00242","article-title":"Interaction of aldehydes derived from lipid peroxidation and membrane proteins","volume":"4","author":"Pizzimenti","year":"2013","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.niox.2019.04.005","article-title":"The effect of nitric oxide on mitochondrial respiration","volume":"88","author":"Poderoso","year":"2019","journal-title":"Nitric Oxide"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb1085","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.pbb.2004.05.018","article-title":"Haloperidol- and clozapine-induced oxidative stress in the rat brain","volume":"78","author":"Polydoro","year":"2004","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb1090","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1176\/appi.ajp.2011.11081153","article-title":"Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder","volume":"169","author":"Pomara","year":"2012","journal-title":"The American Journal of Psychiatry"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107520_bb1095","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.mp.4001511","article-title":"Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress","volume":"9","author":"Prabakaran","year":"2004","journal-title":"Molecular Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb1100","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrn3722","article-title":"Microglia and brain macrophages in the molecular age: From origin to neuropsychiatric disease","volume":"15","author":"Prinz","year":"2014","journal-title":"Nature Reviews. Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb1105","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.molcel.2012.12.014","article-title":"Redox-dependent control of FOXO\/DAF-16 by transportin-1","volume":"49","author":"Putker","year":"2013","journal-title":"Molecular Cell"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1110","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-244X-11-124","article-title":"Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients","volume":"11","author":"Raffa","year":"2011","journal-title":"BMC Psychiatry"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107520_bb1115","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.pnpbp.2009.06.018","article-title":"Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients","volume":"33","author":"Raffa","year":"2009","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1120","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pnpbp.2013.02.007","article-title":"Sex differences in lipid peroxidation and fatty acid levels in recent onset schizophrenia","volume":"44","author":"Ramos-Loyo","year":"2013","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb1125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-1781(03)00220-8","article-title":"Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients","volume":"121","author":"Ranjekar","year":"2003","journal-title":"Psychiatry Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb1130","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1017\/S0033291716002932","article-title":"Cognitive effects of adjunctive N-acetyl cysteine in psychosis","volume":"47","author":"Rapado-Castro","year":"2017","journal-title":"Psychological Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb1140","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-9964(02)00407-3","article-title":"Reduced plasma antioxidants in first-episode patients with schizophrenia","volume":"62","author":"Reddy","year":"2003","journal-title":"Schizophrenia Research"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2020.107520_bb1145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2004.09.032","article-title":"Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain","volume":"372","author":"Reinke","year":"2004","journal-title":"Neuroscience Letters"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107520_bb5005","doi-asserted-by":"crossref","first-page":"1286-81","DOI":"10.1002\/dneu.22283","article-title":"A single dose of S-ketamine induces long-term antidepressant effects and decreases oxidative stress in adulthood rats following maternal deprivation.","volume":"75","author":"R\u00e9us","year":"2015","journal-title":"Developmental Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuroscience.2017.04.016","article-title":"Ketamine potentiates oxidative stress and influences behavior and inflammation in response to lipolysaccharide (LPS) exposure in early life","volume":"353","author":"R\u00e9us","year":"2017","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb1155","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4161\/oxim.3.5.13109","article-title":"Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus","volume":"3","author":"R\u00e9us","year":"2010","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1160","doi-asserted-by":"crossref","first-page":"987397","DOI":"10.1155\/2012\/987397","article-title":"Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain","volume":"2012","author":"R\u00e9us","year":"2012","journal-title":"Depression Research and Treatment"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb1165","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00702-011-0718-2","article-title":"Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain","volume":"119","author":"R\u00e9us","year":"2012","journal-title":"Journal of Neural Transmission (Vienna)"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2020.107520_bb1170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.schres.2013.10.040","article-title":"Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: Reversal by clozapine","volume":"151","author":"Ribeiro","year":"2013","journal-title":"Schizophrenia Research"},{"issue":"Pt 1","key":"10.1016\/j.pharmthera.2020.107520_bb1175","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/bj3590139","article-title":"Nitric oxide inhibits mitochondrial NADH:ubiquinone reductase activity through peroxynitrite formation","volume":"359","author":"Riob\u00f3","year":"2001","journal-title":"The Biochemical Journal"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107520_bb1180","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/mp.2009.53","article-title":"Association of common copy number variants at the glutathione S-transferase genes and rare novel genomic changes with schizophrenia","volume":"15","author":"Rodr\u00edguez-Santiago","year":"2010","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.freeradbiomed.2016.12.046","article-title":"Linking lipid peroxidation and neuropsychiatric disorders: Focus on 4-hydroxy-2-nonenal","volume":"111","author":"Romano","year":"2017","journal-title":"Free Radical Biology & Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107520_bb1195","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/ijnp\/pyy046","article-title":"Chronic stress exposure reduces parvalbumin expression in the rat hippocampus through an imbalance of redox mechanisms: Restorative effect of the antipsychotic lurasidone","volume":"21","author":"Rossetti","year":"2018","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.freeradbiomed.2013.05.019","article-title":"Interplay between the pro-oxidant and antioxidant systems and proinflammatory cytokine levels, in relation to iron metabolism and the erythron in depression","volume":"63","author":"Rybka","year":"2013","journal-title":"Free Radical Biology & Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb1205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/jpet.116.237503","article-title":"Oxidative stress and the central nervous system","volume":"360","author":"Salim","year":"2017","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb1210","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12906-017-1753-9","article-title":"Protective effects of carnosol against oxidative stress induced brain damage by chronic stress in rats","volume":"17","author":"Samarghandian","year":"2017","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1215","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuroscience.2018.01.008","article-title":"Advantages of the alpha-lipoic acid association with chlorpromazine in a model of schizophrenia induced by ketamine in rats: Behavioral and oxidative stress evidences","volume":"373","author":"Sampaio","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1220","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neuropharm.2013.11.004","article-title":"NRF2-regulation in brain health and disease: Implication of cerebral inflammation","volume":"79","author":"Sandberg","year":"2014","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb1225","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hup.829","article-title":"Major depressive disorder is accompanied with oxidative stress: Short-term antidepressant treatment does not alter oxidative-antioxidative systems","volume":"22","author":"Sarandol","year":"2007","journal-title":"Human Psychopharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb1230","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neuron.2014.08.028","article-title":"Is prophylactic psychiatry around the corner? Combating adolescent oxidative stress for adult psychosis and schizophrenia","volume":"83","author":"Sawa","year":"2014","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107520_bb1235","first-page":"964","article-title":"Acetaminophen poisoning: A case report of the use of acetylcysteine","volume":"35","author":"Scalley","year":"1978","journal-title":"American Journal of Hospital Pharmacy"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb1240","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/11633190-000000000-00000","article-title":"Antioxidants as antidepressants: Fact or fiction?","volume":"26","author":"Scapagnini","year":"2012","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb1245","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.biopsych.2009.04.033","article-title":"Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats","volume":"66","author":"Schiavone","year":"2009","journal-title":"Biological Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107520_bb1250","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jpsychires.2008.11.005","article-title":"Impact of haloperidol and quetiapine on the expression of genes encoding antioxidant enzymes in human neuroblastoma SH-SY5Y cells","volume":"43","author":"Schmidt","year":"2009","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb1255","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/npp.2014.95","article-title":"Neurodevelopment, GABA system dysfunction, and schizophrenia","volume":"40","author":"Schmidt","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb1260","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10715762.2015.1077385","article-title":"Thiyl radicals and induction of protein degradation","volume":"50","author":"Sch\u00f6neich","year":"2016","journal-title":"Free Radical Research"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2020.107520_bb1265","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jad.2007.08.006","article-title":"The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode","volume":"107","author":"Selek","year":"2008","journal-title":"Journal of Affective Disorders"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2020.107520_bb1270","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0165-0327(03)00135-6","article-title":"Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression","volume":"80","author":"Selley","year":"2004","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1275","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pnpbp.2017.11.001","article-title":"Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial","volume":"82","author":"Sepehrmanesh","year":"2018","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2020.107520_bb1280","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.psychres.2015.07.036","article-title":"Increased oxidative stress and oxidative DNA damage in non-remission schizophrenia patients","volume":"229","author":"Sertan Copoglu","year":"2015","journal-title":"Psychiatry Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107520_bb1285","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1096\/fj.07-8200com","article-title":"Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression","volume":"21","author":"Shan","year":"2007","journal-title":"The FASEB Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb1290","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00213-017-4762-y","article-title":"Chronic N-acetylcysteine treatment alleviates acute lipopolysaccharide-induced working memory deficit through upregulating caveolin-1 and synaptophysin in mice","volume":"235","author":"Shen","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1295","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jpsychires.2018.02.007","article-title":"Maternal immune activation induced by lipopolysaccharide triggers immune response in pregnant mother and fetus, and induces behavioral impairment in adult rats","volume":"100","author":"Sim\u00f5es","year":"2018","journal-title":"Journal of Psychiatric Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb1300","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/0019-5545.43627","article-title":"A comparative study of oxidative stress and interrelationship of important antioxidants in haloperidol and olanzapine treated patients suffering from schizophrenia","volume":"50","author":"Singh","year":"2008","journal-title":"Indian Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb1305","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.pnpbp.2012.06.018","article-title":"N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: Behavioral and biochemical analyses in rats","volume":"39","author":"Smaga","year":"2012","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb1310","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuint.2012.04.008","article-title":"Chronic acetyl-L-carnitine alters brain energy metabolism and increases noradrenaline and serotonin content in healthy mice","volume":"61","author":"Smeland","year":"2012","journal-title":"Neurochemistry International"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107520_bb1315","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ijnp\/pyx017","article-title":"Modulating oxidative stress relieves stress-induced behavioral and cognitive impairments in rats","volume":"20","author":"Solanki","year":"2017","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb1320","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11064-008-9838-y","article-title":"Prenatal stress causes oxidative damage to mitochondrial DNA in hippocampus of offspring rats","volume":"34","author":"Song","year":"2009","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2020.107520_bb5000","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuint.2018.08.006","article-title":"\u03b1-(phenylselanyl) acetophenone abolishes acute restraint stress induced-comorbid pain, depression and anxiety-related behaviors in mice","volume":"120","author":"Sousa","year":"2018","journal-title":"Neurochemistry International"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107520_bb6000","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.psyneuen.2013.05.011","article-title":"Acute restraint stress induces rapid and prolonged changes in erythrocyte and hippocampal redox status","volume":"38","author":"Spiers","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1325","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpsychires.2017.06.006","article-title":"The impact of chronic mild stress on long-term depressive behavior in rats which have survived sepsis","volume":"94","author":"Steckert","year":"2017","journal-title":"Journal of Psychiatric Research"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2020.107520_bb1335","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jad.2012.05.022","article-title":"The relevance of oxidative stress status in first episode and recurrent depression","volume":"143","author":"Stefanescu","year":"2012","journal-title":"Journal of Affective Disorders"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107520_bb1340","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/mp.2017.47","article-title":"Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia","volume":"22","author":"Steullet","year":"2017","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb1345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0974-8490.171100","article-title":"Effect of Beta vulgaris Linn. Leaves extract on anxiety- and depressive-like behavior and oxidative stress in mice after acute restraint stress","volume":"8","author":"Sulakhiya","year":"2016","journal-title":"Pharmacognosy Research"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2020.107520_bb1350","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0165-0327(00)00164-6","article-title":"Elevated plasma nitrate levels in depressive states","volume":"63","author":"Suzuki","year":"2001","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb1355","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00213-017-4776-5","article-title":"N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges","volume":"235","author":"Swanepoel","year":"2018","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107520_bb1360","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1017\/S1461145714000698","article-title":"Shortened telomere length in white matter oligodendrocytes in major depression: Potential role of oxidative stress","volume":"17","author":"Szebeni","year":"2014","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb1365","first-page":"363","article-title":"Elevated DNA oxidation and DNA repair enzyme expression in brain white matter in major depressive disorder","volume":"20","author":"Szebeni","year":"2017","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb1370","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2443.2010.01473.x","article-title":"Molecular mechanisms of the Keap1\u2013Nrf2 pathway in stress response and cancer evolution","volume":"16","author":"Taguchi","year":"2011","journal-title":"Genes to Cells"},{"issue":"15","key":"10.1016\/j.pharmthera.2020.107520_bb1375","doi-asserted-by":"crossref","first-page":"13304","DOI":"10.1074\/jbc.M110.192138","article-title":"The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4","volume":"286","author":"Takac","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb1380","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jphs.2018.06.006","article-title":"Antidepressant-like effect of aripiprazole via 5-HT","volume":"137","author":"Takahashi","year":"2018","journal-title":"Journal of Pharmacological Sciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb1385","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1007\/s11033-011-1335-8","article-title":"Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder","volume":"39","author":"Talarowska","year":"2012","journal-title":"Molecular Biology Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb1390","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1073\/pnas.0609737104","article-title":"Oxidized messenger RNA induces translation errors","volume":"104","author":"Tanaka","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb1395","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bbr.2011.02.018","article-title":"Differential effects of inescapable stress on locus coeruleus GRK3, alpha2-adrenoceptor and CRF1 receptor levels in learned helpless and non-helpless rats: A potential link to stress resilience","volume":"221","author":"Taneja","year":"2011","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1400","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.brainresbull.2019.01.018","article-title":"Atorvastatin prevents lipopolysaccharide-induced depressive-like behavior in mice","volume":"146","author":"Taniguti","year":"2019","journal-title":"Brain Research Bulletin"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107520_bb1405","first-page":"417","article-title":"L-acetylcarnitine in depressed elderly subjects. A cross-over study vs placebo","volume":"13","author":"Tempesta","year":"1987","journal-title":"Drugs under Experimental and Clinical Research"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1410","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.physbeh.2017.07.010","article-title":"Silymarin ameliorates experimentally induced depressive like behavior in rats: Involvement of hippocampal BDNF signaling, inflammatory cytokines and oxidative stress response","volume":"179","author":"Thakare","year":"2017","journal-title":"Physiology & Behavior"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb1415","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11011-016-9922-y","article-title":"Attenuation of acute restraint stress-induced depressive like behavior and hippocampal alterations with protocatechuic acid treatment in mice","volume":"32","author":"Thakare","year":"2017","journal-title":"Metabolic Brain Disease"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1425","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.imlet.2017.08.016","article-title":"The phagocyte respiratory burst: Historical perspectives and recent advances","volume":"192","author":"Thomas","year":"2017","journal-title":"Immunology Letters"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1430","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuroscience.2014.03.025","article-title":"Antidepressant-like effect of nitric oxide synthase inhibitors and sildenafil against lipopolysaccharide-induced depressive-like behavior in mice","volume":"268","author":"Tomaz","year":"2014","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb1435","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1086\/507566","article-title":"Schizophrenia and oxidative stress: Glutamate cysteine ligase modifier as a susceptibility gene","volume":"79","author":"Tosic","year":"2006","journal-title":"American Journal of Human Genetics"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107520_bb1440","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/asj.12809","article-title":"Social defeat models in animal science: What we have learned from rodent models","volume":"88","author":"Toyoda","year":"2017","journal-title":"Animal Science Journal"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107520_bb1445","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1177\/0269881118795244","article-title":"Clozapine attenuates mitochondrial burdens and abnormal behaviors elicited by phencyclidine in mice via inhibition of p47","volume":"32","author":"Tran","year":"2018","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107520_bb8000","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.fct.2017.10.019","article-title":"Ginsenoside Re protects against phencyclidine-induced behavioral changes and mitochondrial dysfunction via interactive modulation of glutathione peroxidase-1 and NADPH oxidase in the dorsolateral cortex of mice.","volume":"110","author":"Tran","year":"2017","journal-title":"Food and Chemical Toxicology"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107520_bb1450","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1007\/s12035-016-0239-y","article-title":"Protective potential of the Glutathione peroxidase-1 gene in abnormal behaviors induced by phencyclidine in mice","volume":"54","author":"Tran","year":"2017","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1455","doi-asserted-by":"crossref","first-page":"248529","DOI":"10.1155\/2015\/248529","article-title":"Psychiatric disorders and polyphenols: Can they be helpful in therapy?","volume":"2015","author":"Trebatick\u00e1","year":"2015","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb1460","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/10715762.2015.1089988","article-title":"One- and two-electron oxidation of thiols: Mechanisms, kinetics and biological fates","volume":"50","author":"Trujillo","year":"2016","journal-title":"Free Radical Research"},{"issue":"7092","key":"10.1016\/j.pharmthera.2020.107520_bb1465","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nature04782","article-title":"S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration","volume":"441","author":"Uehara","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1470","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.biopha.2018.06.016","article-title":"Naringenin attenuates behavioral derangements induced by social defeat stress in mice via inhibition of acetylcholinesterase activity, oxidative stress and release of pro-inflammatory cytokines","volume":"105","author":"Umukoro","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2020.107520_bb1475","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neulet.2005.04.052","article-title":"Age-dependent effects of maternal deprivation on oxidative stress in infant rat brain","volume":"384","author":"Uysal","year":"2005","journal-title":"Neuroscience Letters"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb1480","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/PSY.0000000000000537","article-title":"Acetyl-L-carnitine supplementation and the treatment of depressive symptoms: A systematic review and meta-analysis","volume":"80","author":"Veronese","year":"2018","journal-title":"Psychosomatic Medicine"},{"issue":"42","key":"10.1016\/j.pharmthera.2020.107520_bb1485","doi-asserted-by":"crossref","first-page":"35372","DOI":"10.1074\/jbc.M503991200","article-title":"Characterization of the oxidase activity in mammalian catalase","volume":"280","author":"Vetrano","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb1490","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.abb.2010.04.018","article-title":"Mechanisms of catalase activity of heme peroxidases","volume":"500","author":"Vlasits","year":"2010","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107520_bb1495","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1017\/S1461145708008882","article-title":"Clozapine causes oxidation of proteins involved in energy metabolism: A possible mechanism for antipsychotic-induced metabolic alterations","volume":"11","author":"Walss-Bass","year":"2008","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb9000","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1399-5618.2009.00717.x","article-title":"Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia.","volume":"11","author":"Wang","year":"2009","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1500","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.pnpbp.2019.04.010","article-title":"Mitochondrial transplantation attenuates lipopolysaccharide- induced depression-like behaviors","volume":"93","author":"Wang","year":"2019","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1505","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ynstr.2016.08.004","article-title":"Prenatal stressors in rodents: Effects on behavior","volume":"6","author":"Weinstock","year":"2017","journal-title":"Neurobiology of Stress"},{"issue":"17","key":"10.1016\/j.pharmthera.2020.107520_bb1510","first-page":"5089","article-title":"The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis","volume":"62","author":"Welsh","year":"2002","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1520","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","article-title":"The chronic mild stress (CMS) model of depression: History, evaluation and usage","volume":"6","author":"Willner","year":"2017","journal-title":"Neurobiology of Stress"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb1525","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.7883\/yoken.JJID.2004.S31","article-title":"Reactions of superoxide with myeloperoxidase and its products","volume":"57","author":"Winterbourn","year":"2004","journal-title":"Japanese Journal of Infectious Diseases"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107520_bb1530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020263","article-title":"Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder","volume":"2","author":"Xu","year":"2005","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb1535","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/1570159X11666131120231448","article-title":"Novel therapeutic targets in depression and anxiety: Antioxidants as a candidate treatment","volume":"12","author":"Xu","year":"2014","journal-title":"Current Neuropharmacology"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107520_bb1540","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.psyneuen.2010.03.010","article-title":"Depression and oxidative damage to lipids","volume":"35","author":"Yager","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1545","doi-asserted-by":"crossref","first-page":"5421528","DOI":"10.1155\/2019\/5421528","article-title":"The antioxidative action of ZTP by increasing Nrf2\/ARE signal pathway","volume":"2019","author":"Yang","year":"2019","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107520_bb1550","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1007\/s00213-018-4949-x","article-title":"Dl-3-n-Butylphthalide improves lipopolysaccharide-induced depressive-like behavior in rats: Involvement of Nrf2 and NF-\u03baB pathways","volume":"235","author":"Yang","year":"2018","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb1555","doi-asserted-by":"crossref","first-page":"319","DOI":"10.18388\/abp.2003_3689","article-title":"Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling","volume":"50","author":"Yang","year":"2003","journal-title":"Acta Biochimica Polonica"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2020.107520_bb1560","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2006\/248387","article-title":"Altered glutathione redox state in schizophrenia","volume":"22","author":"Yao","year":"2006","journal-title":"Disease Markers"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1565","doi-asserted-by":"crossref","first-page":"30659","DOI":"10.1038\/srep30659","article-title":"Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice","volume":"6","author":"Yao","year":"2016","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb1570","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000098367","article-title":"Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia","volume":"16","author":"Yilmaz","year":"2007","journal-title":"Medical Principles and Practice"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb1575","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","article-title":"The therapeutic potential of monoamine oxidase inhibitors","volume":"7","author":"Youdim","year":"2006","journal-title":"Nature Reviews. Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb1580","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ptr.5550","article-title":"Baicalin reverses depressive-like behaviors and regulates apoptotic signalling induced by olfactory bulbectomy","volume":"30","author":"Yu","year":"2016","journal-title":"Phytotherapy Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107520_bb1585","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/10253890802234168","article-title":"Modulation of in vivo oxidative status by exogenous corticosterone and restraint stress in rats","volume":"12","author":"Zafir","year":"2009","journal-title":"Stress"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb1590","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.euroneuro.2005.10.005","article-title":"A double-blind, randomised, controlled clinical trial of acetyl-L-carnitine vs. amisulpride in the treatment of dysthymia","volume":"16","author":"Zanardi","year":"2006","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107520_bb1595","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.steroids.2017.07.006","article-title":"Ferulic acid reverses depression-like behavior and oxidative stress induced by chronic corticosterone treatment in mice","volume":"125","author":"Zeni","year":"2017","journal-title":"Steroids"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107520_bb1600","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00406-017-0848-0","article-title":"Keap1-Nrf2 signaling pathway confers resilience versus susceptibility to inescapable electric stress","volume":"268","author":"Zhang","year":"2018","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107520_bb1605","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1007\/s12035-016-0111-0","article-title":"Nrf2-a Promising therapeutic target for defensing against oxidative stress in stroke","volume":"54","author":"Zhang","year":"2017","journal-title":"Molecular Neurobiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107520_bb1610","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/schbul\/sbt045","article-title":"Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls","volume":"40","author":"Zhang","year":"2014","journal-title":"Schizophrenia Bulletin"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107520_bb1615","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-1781(02)00303-7","article-title":"Elevated blood superoxide dismutase in neuroleptic-free schizophrenia: Association with positive symptoms","volume":"117","author":"Zhang","year":"2003","journal-title":"Psychiatry Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107520_bb1620","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/acps.12862","article-title":"N-acetylcysteine for major mental disorders: A systematic review and meta-analysis of randomized controlled trials","volume":"137","author":"Zheng","year":"2018","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107520_bb1625","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/jnr.20338","article-title":"Prenatal stress causes gender-dependent neuronal loss and oxidative stress in rat hippocampus","volume":"78","author":"Zhu","year":"2004","journal-title":"Journal of Neuroscience Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb1630","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10863-017-9718-8","article-title":"Manganese superoxide dismutase (SOD2): Is there a center in the universe of mitochondrial redox signaling?","volume":"49","author":"Zou","year":"2017","journal-title":"Journal of Bioenergetics and Biomembranes"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107520_bb1635","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s11011-015-9671-3","article-title":"Maternal deprivation disrupts mitochondrial energy homeostasis in the brain of rats subjected to ketamine-induced schizophrenia","volume":"30","author":"Zugno","year":"2015","journal-title":"Metabolic Brain Disease"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820300486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820300486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:05:27Z","timestamp":1759010727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725820300486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":323,"alternative-id":["S0163725820300486"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107520","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107520"}}